A Phase III Study to Investigate the Impact of Diamyd® in Patients Newly Diagnosed With Type 1 Diabetes (USA) - Full Text View - ClinicalTrials.gov
This is the same phase III that was started earlier this year in Europe.
Diamyd has, for the moment, probably the best chance to develop a substance for type 1 diabetes patients.
Diamyd Medical AB - Diamyd kicks off recruitment campaign for Phase III in the US
This is the same phase III that was started earlier this year in Europe.
Diamyd has, for the moment, probably the best chance to develop a substance for type 1 diabetes patients.
Diamyd Medical AB - Diamyd kicks off recruitment campaign for Phase III in the US